why choose us

First received: August 09, 2022

Clinical Trial: A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SPR720 as Compared With Placebo for the Treatment of Participants With Mycobacterium Avium Complex (MAC) Pulmonary Disease

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-Blinded, Placebo-Controlled, Multicenter, Phase 2, Dose-Ranging Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SPR720 as Compared With Placebo for t

Brief Summary: The purpose of the study is to evaluateThe microbiological response and clinical efficacy of SPR720 compared with placebo in participants with nontuberculous mycobacteria pulmonary disease (NTM-PD).The safety and tolerability of SPR720 in a participants population with NTM- PDThe pharmacokinetic (PK) of SPR719, active moiety, following orally (po) administered prodrug SPR720 in a participant population with NTM-PD.

Read more